Sample overview
| Project Name |
TARGET-RT
|
| GSE ID |
GSE195709
|
| GSM ID |
GSM5848677
|
| Cell Line |
RD cell line
|
| Tissue type |
None
|
| Disease Type |
Rhabdomyosarcoma
|
| PMID |
35982179
|
| Initial gene number |
32738
|
| Initial cell number |
2619
|
| Post-QC gene number |
2196
|
| Post-QC cell number |
2427
|
Bulk-to-ScRNA-seq Label Transfer
Bulk phenotype-associated subpopulations
Reference-Based Annotation
Differentially expressed genes
Overall Survival : Cluster
vs
There are no results of the analysis here
Overall Survival : Cluster
vs ( + )
There are no results of the analysis here
Clinical Stage : Cluster
vs
There
are no results of the analysis here
Tumor Size : Cluster
vs
There
are no results of the analysis here
Lymph Node Involvement : Cluster
vs
There
are no results of the analysis here
Distant Metastasis : Cluster
vs
There
are no results of the analysis here
Cell-Cell communications ( Survival-Associated Subpopulations Across Cell Types )
Cell Population Signaling and Communication
Ligand-Receptor-Mediated Cell-Cell Interactions
| Sending Cell Type |
Ligand |
Receiving Cell Type |
Receptor |
Score |
P-value |
Pathway Name |
Function |
Evidence |
| Erythrocytes(Nos)_source |
MDK_ligand |
Erythrocytes(Nos)_target |
SDC2_receptor |
1.587e-03 |
0.0 |
MK |
Secreted Signaling |
PMID: 28356350 |
| Erythrocytes(Nos)_source |
MDK_ligand |
Fibroblasts(Nos)_target |
SDC2_receptor |
1.957e-03 |
0.0 |
MK |
Secreted Signaling |
PMID: 28356350 |
| Fibroblasts(Nos)_source |
MDK_ligand |
Fibroblasts(Nos)_target |
SDC2_receptor |
4.618e-04 |
0.0 |
MK |
Secreted Signaling |
PMID: 28356350 |
| Skeletal,muscle(Nos)_source |
MDK_ligand |
Fibroblasts(Nos)_target |
SDC2_receptor |
4.303e-04 |
0.0 |
MK |
Secreted Signaling |
PMID: 28356350 |
| Erythrocytes(Nos)_source |
MDK_ligand |
HSC(Nos)_target |
SDC2_receptor |
2.805e-03 |
0.0 |
MK |
Secreted Signaling |
PMID: 28356350 |
| Fibroblasts(Nos)_source |
MDK_ligand |
HSC(Nos)_target |
SDC2_receptor |
6.601e-04 |
0.0 |
MK |
Secreted Signaling |
PMID: 28356350 |
| Skeletal,muscle(Nos)_source |
MDK_ligand |
HSC(Nos)_target |
SDC2_receptor |
6.150e-04 |
0.02 |
MK |
Secreted Signaling |
PMID: 28356350 |
| Erythrocytes(Nos)_source |
MDK_ligand |
Skeletal,muscle(Nos)_target |
SDC2_receptor |
2.014e-03 |
0.0 |
MK |
Secreted Signaling |
PMID: 28356350 |
| Fibroblasts(Nos)_source |
MDK_ligand |
Skeletal,muscle(Nos)_target |
SDC2_receptor |
4.754e-04 |
0.0 |
MK |
Secreted Signaling |
PMID: 28356350 |
| Skeletal,muscle(Nos)_source |
MDK_ligand |
Skeletal,muscle(Nos)_target |
SDC2_receptor |
4.430e-04 |
0.0 |
MK |
Secreted Signaling |
PMID: 28356350 |
| Erythrocytes(Nos)_source |
MDK_ligand |
Erythrocytes(Nos)_target |
NCL_receptor |
4.636e-03 |
0.0 |
MK |
Secreted Signaling |
PMID: 28356350 |
| Fibroblasts(Nos)_source |
MDK_ligand |
Erythrocytes(Nos)_target |
NCL_receptor |
1.097e-03 |
0.0 |
MK |
Secreted Signaling |
PMID: 28356350 |
| Skeletal,muscle(Nos)_source |
MDK_ligand |
Erythrocytes(Nos)_target |
NCL_receptor |
1.022e-03 |
0.0 |
MK |
Secreted Signaling |
PMID: 28356350 |
| Erythrocytes(Nos)_source |
MDK_ligand |
Fibroblasts(Nos)_target |
NCL_receptor |
1.866e-03 |
0.0 |
MK |
Secreted Signaling |
PMID: 28356350 |
| Fibroblasts(Nos)_source |
MDK_ligand |
Fibroblasts(Nos)_target |
NCL_receptor |
4.401e-04 |
0.03 |
MK |
Secreted Signaling |
PMID: 28356350 |
| Erythrocytes(Nos)_source |
MDK_ligand |
HSC(Nos)_target |
NCL_receptor |
3.039e-03 |
0.0 |
MK |
Secreted Signaling |
PMID: 28356350 |
| Fibroblasts(Nos)_source |
MDK_ligand |
HSC(Nos)_target |
NCL_receptor |
7.162e-04 |
0.03 |
MK |
Secreted Signaling |
PMID: 28356350 |
| Erythrocytes(Nos)_source |
MDK_ligand |
Skeletal,muscle(Nos)_target |
NCL_receptor |
2.185e-03 |
0.0 |
MK |
Secreted Signaling |
PMID: 28356350 |
| Fibroblasts(Nos)_source |
MDK_ligand |
Skeletal,muscle(Nos)_target |
NCL_receptor |
5.166e-04 |
0.0 |
MK |
Secreted Signaling |
PMID: 28356350 |
| Skeletal,muscle(Nos)_source |
MDK_ligand |
Skeletal,muscle(Nos)_target |
NCL_receptor |
4.815e-04 |
0.0 |
MK |
Secreted Signaling |
PMID: 28356350 |